Cancer News and Research

Latest Cancer News and Research

FDA approves new treatment for people with hairy cell leukemia

AstraZeneca and MedImmune, its global biologics research and development arm, announced today that the US Food and Drug Administration has approved LUMOXITI (moxetumomab pasudotox-tdfk) for the treatment of adult patients with relapsed or refractory hairy cell leukemia who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog.

14 Sep 2018

MAPK pathway mediates normal kidney development, reveals study

The prevalence of kidney diseases is growing rapidly due to an aging population and an increased incidence of diseases like diabetes.

14 Sep 2018

Study: Children with acute lymphoblastic leukemia are immunologically disparate at birth

Neonatal concentrations of eight detectable inflammatory markers were significantly different in children later diagnosed with B-cell precursor acute lymphoblastic leukemia (ALL) compared with controls.

14 Sep 2018

Study could pave way for new therapies to reverse aging in human cells

Research has shed new light on genetic processes that may one day lead to the development of therapies that can slow, or even reverse, how our cells age.

14 Sep 2018

Twice-a-year MRI more effective than mammograms for women with genetic breast cancer risk

Getting magnetic resonance imaging scans twice a year instead of one annual mammogram is far more effective at detecting early breast cancers in young women with a high-risk genetic profile than mammograms alone, according to a research team based at the University of Chicago Medicine and the University of Washington, Seattle.

14 Sep 2018

Scientists get unprecedented view of brain development through high-resolution genomic map

Researchers at St. Jude Children's Research Hospital have created a massive database of the changes in gene activity of individual cells in the cerebellum during embryonic development and immediately after birth.

14 Sep 2018

US Department of Defense offers three-year grant for UIC study on prostate cancer

A new three-year grant totaling nearly $1 million from the U.S. Department of Defense will fund University of Illinois at Chicago research on the gene SELENOF and its role in the development of prostate cancer among black men.

14 Sep 2018

Medicare incurs more than $1.2 billion over prostate cancer care in older men

Researchers from the University of North Carolina Lineberger Comprehensive Cancer Center estimate that screening for and treating prostate cancer in men aged 70 years or older, which is not recommended by national guidelines, cost Medicare more than $1.2 billion over a three year period for each group of men diagnosed in the United States each year.

14 Sep 2018

Beauty products contain mixed chemicals that may harm women's hormones

As we go about our daily lives, we are exposed to many different chemicals that could have negative effects on our hormones.

14 Sep 2018

New clinical trial initiated on experimental vaccine to stop the spread of glioblastoma

Rush University Medical Center is part of a new clinical trial testing whether an experimental vaccine can help patients' immune systems stop the spread of glioblastoma -- an aggressive form of brain cancer with veryhttps://www.rush.edu/news/press-releases/rush-testing-new-brain-cancer-vaccine few current treatment options.

14 Sep 2018

Discovery of key mechanism may lead to more functional skin grafts for burn victims

University of Colorado Boulder researchers have discovered a key mechanism by which skin begins to develop in embryos, shedding light on the genetic roots of birth defects like cleft palate and paving the way for development of more functional skin grafts for burn victims.

14 Sep 2018

Novel treatment for hairy cell leukemia approved by FDA

The U.S. Food and Drug Administration today approved Lumoxiti (moxetumomab pasudotox-tdfk) injection for intravenous use for the treatment of adult patients with relapsed or refractory hairy cell leukemia (HCL) who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog.

14 Sep 2018

Adhering to anti-inflammatory diet may reduce risk of early death

Adhering to an anti-inflammatory diet was associated with lower risks of dying from any cause, dying from cardiovascular causes, and dying from cancer in a recent Journal of Internal Medicine study.

14 Sep 2018

Podcast: KHN’s ‘What the Health?’ A detour on a smoking off-ramp

The Food and Drug Administration declared Wednesday that vaping among teenagers has reached "an epidemic proportion." The agency told ﬁve major e-cigarette manufacturers that they had 60 days to find ways to keep their products away from minors.

14 Sep 2018

Aging may have originated at the very beginning of life, says study

A new USC Dornsife study indicates that aging may have originated at the very beginning of the evolution of life, at the same time as the evolution of the first genes.

13 Sep 2018

Is ‘precision medicine’ the answer to cancer? Not precisely.

Facing incurable breast cancer at age 55, MaryAnne DiCanto put her faith in "precision medicine" — in which doctors try to match patients with drugs that target the genetic mutations in their tumors. She underwent repeated biopsies to identify therapies that might help.

13 Sep 2018

Annual survey highlights poor awareness of sepsis in the US

A new survey has revealed that, although awareness of sepsis is increasing in the US, there are still very few people who are able to recognize the symptoms.

13 Sep 2018

Cancer to kill nearly 10 million this year says WHO report

According to a report released by the World Health Organization’s cancer research agency this week, 9.6 million people would lose their lives to cancer this year. This translates as one in eight of all deaths and one in eleven of all deaths among men and women respectively says the agency.

13 Sep 2018

Study provides complete picture of HPV virus-head and neck cancer connections

Human papillomavirus is widely known to cause nearly all cases of cervical cancer. However, you might not know that HPV also causes 70 percent of oropharyngeal cancer, a subset of head and neck cancers that affect the mouth, tongue, and tonsils.

12 Sep 2018

Drug combination targets pre-leukemia stem cells

Your body's blood cells are manufactured by hematopoietic stem cells in bone marrow. But just as regular, mature cells can become cancerous, so too can stem cells.

12 Sep 2018